Recent Press Releases

SRI International Opens Clinical Trial Unit in Michigan Life Science Innovation Center

MENLO PARK, Calif. -- SRI Biosciences, a division of SRI International, has completed construction of an early-phase clinical trial facility in Plymouth, Michigan. The 9,400-square foot unit, located...

Veeva Vault Selected by inVentiv Health Clinical to Empower Sponsors with Cloud-based eTMF Clinical Trial Platform

Clients benefit from complete access, visibility, and control throughout the clinical trial inVentiv Health Clinical, a leading global supplier of drug development services, will replace its...

Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China

Ge Li, chairman and chief executive officer of WuXi. "WuXi has seen rapidly increasing demand for molecular profiling services from biopharmaceutical companies as they scale up R&D...

Charles River Laboratories Introduces PTS-Micro™ System for Rapid Microbial Burden Testing

WILMINGTON, Mass.—October 20, 2014 – Charles River Laboratories International, Inc. (NYSE: CRL) today introduced the PTS-Micro™ system, a new technology platform designed for rapid...

DKSH extends relationship with Roche across Asia

DKSH, the leading Market Expansion Services provider with a focus on Asia, has signed an agreement with Roche to extend the duration of its decades-long partnership across Asian markets and expand...

INC Research Signs Agreement to Perform FDA Due Diligence Audit of Regulatory Documents for Provectus Biopharmaceuticals

KNOXVILLE, Tenn.--Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT) (http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company ("Provectus"), announced...

Catalent Applied Drug Delivery Institute To Collaborate With Lung Cancer Alliance To Conduct Patient Research

Somerset, N.J. — The Catalent Applied Drug Delivery Institute today announced that it is to collaborate with the Lung Cancer Alliance on patient research in early October. The collaboration...

Charles River's Early Drug Discovery Collaboration with AstraZeneca Delivers Respiratory Candidate Drug

WILMINGTON, Mass.--Charles River Laboratories International, Inc. announced today that its integrated drug discovery collaboration with AstraZeneca has delivered an oral respiratory candidate drug...

BioPharma Services Inc. Announces the Grand Opening of Its Clinical Operations in the US

TORONTO--BioPharma Services Inc. (BPSI), a full service clinical research organization (CRO), announces the grand opening of its new 48-bed Phase 1 Clinical Facility in Columbia, Missouri which is...

genae Opens Offices in New York City

ANTWERP, Belgium and NEW YORK -- genae, a global Contract Research Organization (CRO) and service provider for the medical industries, announced today the expansion of its North American activities...

Former VP, Oncology, from Pfizer and Otsuka Joins Accelovance to Augment Oncology Growth

ROCKVILLE, Md. -- Accelovance, Inc. (Accelovance), a contract research organization (CRO) focusing in early phase oncology, vaccines, and general medicine, today announced that Dr. Joseph D. Purvis...

Chiltern acquires Pacific Clinical Research Pte Limited and expands operations and therapeutic depth in Asia-Pacific

LONDON and WILMINGTON, N.C. -- Chiltern has acquired Pacific Clinical Research, a pan-Asian CRO based in Singapore. The move allows Chiltern to offer integrated services throughout the Asia-Pacific...

Catalent Expands Its Technology Offerings in Biologics, Acquires Redwood Bioscience Inc. and the SMARTagT Technology Platform

SOMERSET, N.J. -- Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today...

WuXi PharmaTech Laboratory Testing Division Expands in U.S. With Acquisition of XenoBiotic Laboratories, Inc.

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (WuXi) (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the...

PAREXEL International Announces Acquisition of ClinIntel, Extending Leadership in Randomization and Trial Supply Management

Boston, MA – PAREXEL International Corporation (Nasdaq: PRXL)("PAREXEL" or the "Company"), a global clinical research organization, announced today that the Company has...

Update on Co-Development Partnerships

Good progress with partnerships and additional clinical studies commenced Guildford, UK: Ergomed plc, (LSE: ERGO) a profitable UK-based company dedicated to the provision of specialised services to...

Evotec and its partners awarded public grants to develop new drug candidates to treat multiple sclerosis

Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that it has entered into three novel research projects for the treatment of Multiple Sclerosis...

Catalent And Cingulate Therapeutics Sign Exclusive Agreement For Development Of New ADHD Treatments

Somerset, N.J. — Catalent Pharma Solutions has reached an exclusive development and licensing agreement with privately held biopharmaceutical company, Cingulate Therapeutics (CTx), to support...

PPD Exercises Option to Acquire Remaining Interest in X-Chem, Inc.

WILMINGTON, N.C. & WALTHAM, Mass.--Pharmaceutical Product Development, LLC (PPD) and X-Chem, Inc. announced today that PPD has exercised its option to acquire the remaining minority ownership...